Phase II trial of vorinostat with idarubicin and cytarabine for patients with newly diagnosed acute myelogenous leukemia or myelodysplastic syndrome (Q36934314)
Jump to navigation
Jump to search
scientific article published on 14 May 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of vorinostat with idarubicin and cytarabine for patients with newly diagnosed acute myelogenous leukemia or myelodysplastic syndrome |
scientific article published on 14 May 2012 |
Statements
1 reference
Phase II trial of vorinostat with idarubicin and cytarabine for patients with newly diagnosed acute myelogenous leukemia or myelodysplastic syndrome (English)
1 reference
Hagop M Kantarjian
1 reference
Stefan Faderl
1 reference
Farhad Ravandi
1 reference
Elias Jabbour
1 reference
Gautam Borthakur
1 reference
Guillermo Garcia-Manero
1 reference
Jorge E Cortes
1 reference
Tapan M Kadia
1 reference
Marina Y Konopleva
1 reference
Mark Brandt
1 reference
Deborah McCue
1 reference
Francesco Paolo Tambaro
1 reference
Nebiyou B Bekele
1 reference
Hui Yang
1 reference
Yumin Hu
1 reference
Willie Mae Newsome
1 reference
Sherry R Pierce
1 reference
Marcos de Lima
1 reference
14 May 2012
1 reference
1 reference
2204-2210
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference